drugset / Trial / NCT00530946

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946

Phase 3 Completed 165 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the changes in the trough Systolic Blood Pressure (SBP) and the percent changes in Low Density Lipoprotein-Cholesterol (LDL-C) from baseline at Week 8 in the treatment period

Timeline

Start
2007-09
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 2.5 mg
Comparator Amlodipine Other / unclassified 5 mg
Comparator Atorvastatin Small molecule 5 mg
Comparator Atorvastatin Small molecule 10 mg